Prostate Cancer - Results from #640

Social Determinants of Health Mediate Racial Disparities in Cardiovascular Disease in Men With Prostate Cancer. July 11, 2024

A vitamin D-based strategy overcomes chemoresistance in prostate cancer. July 11, 2024

Impact of homologous recombination repair/BReast CAncer (BRCA) gene alterations on survival in a real-world setting of metastatic prostate cancer. July 11, 2024

Regulatory and memory T lymphocytes infiltrating prostate tumors predict long term clinical outcomes. July 11, 2024

Longer prostate stromal cell telomere length is associated with increased risk of death from other cancers. July 11, 2024

From Despair to Hope: First Arabic Experience of 177Lu-PSMA and 161Tb-PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer. July 11, 2024

Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancer. July 11, 2024

Artificial Intelligence and Radiologists in Prostate Cancer Detection on MRI (PI-CAI): An International, Paired, Non-Inferiority, Confirmatory Study July 10, 2024

SHP2 as a primordial epigenetic enzyme expunges histone H3 pTyr-54 to amend androgen receptor homeostasis. July 10, 2024

Evaluating recommendation-based dietary and physical activity strategies for prostate cancer prevention: a target trial emulation in the Health Professionals Follow-up Study. July 10, 2024

Biological determinants of PSMA expression, regulation and heterogeneity in prostate cancer. July 10, 2024

The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. July 10, 2024

Reducing Prostate Cancer Disparities for Black Men. July 10, 2024

JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression. July 10, 2024

Preclinical evidence for the use of anti-Trop-2 antibody-drug conjugate Sacituzumab govitecan in cerebral metastasized castration-resistant prostate cancer. July 10, 2024

Fluorine-18 Prostate-Specific Membrane Antigen–1007 PET/CT vs Multiparametric MRI for Locoregional Staging of Prostate Cancer July 9, 2024

Circulating Tumor Extracellular Vesicles to Monitor Metastatic Prostate Cancer Genomics and Transcriptomic Evolution July 9, 2024

Molecular and diffusion features for identification of clinically significant prostate cancer in PI-RADS 3 lesions. July 9, 2024

A case-cohort study of per- and polyfluoroalkyl substance concentrations and incident prostate cancer in the Cancer Prevention Study-II LifeLink Cohort study. July 9, 2024

Stereotactic Body Proton Therapy Versus Conventionally Fractionated Proton Therapy for Early Prostate Cancer: A Randomized, Controlled, Phase 3 Trial. July 9, 2024

Page 33 of 1437